Getinge Interim Report January-June 2016
Second quarter of 2016 in brief
- Order intake: -0.7% to SEK 7,460 M (7,516). The order intake grew organically by 3.0%.
- Net sales: -3.5% to SEK 6,927 M (7,181). Net sales fell organically by 0.3%.
- Gross margin: 45.7% (46.4). Affected negatively by currencies.
- EBITA*: +10.2% to SEK 788 M (715).
- Restructuring and integration costs: SEK 133 M (86).
- Profit before tax: +28.0% to SEK 311 M (243).
- Earnings per share: SEK 0.93 (0.71).
- Good cost control: Administrative and selling expenses declined by 8.4%.
- New President of Acute Care Therapies: Jens Viebke
- FDA update: Getinge is still awaiting a decision by the FDA regarding the remediation plan in Hechingen.
- Strengthened customer offering: Launches include a new mobile operating table.
January-June 2016 in brief
- Order intake: -2.2% to SEK 14,384 M (14,708). The order intake grew organically by 0.5%.
- Net sales: -4.2% to SEK 13,304 M (13,893). Net sales fell organically by 1.7%.
- Gross margin: 46.4% (46.6).
- EBITA*: -1.7% to SEK 1,408 M (1,432).
- Restructuring and integration costs: SEK 260 M (270).
- Profit before tax: +20.6% to SEK 468 M (388).
- Earnings per share: SEK 1.39 (1.09).
- The transformation and efficiency-enhancement program was initiated and a Group-wide sales organization was established.
Financial summary
| MSEK | Q2 2016 | Q2 2015 | Change % | Jan-Jun 2016 | Jan-Jun 2015 | Change % | Rolling 12M | FY 2015 |
| Order intake | 7 460 | 7 516 | -0.7% | 14 384 | 14 708 | -2.2% | 30 107 | 30 431 |
| Net sales | 6 927 | 7 181 | -3.5% | 13 304 | 13 893 | -4.2% | 29 646 | 30 235 |
| Gross Profit | 3 167 | 3 331 | -4.9% | 6 178 | 6 473 | -4.6% | 13 868 | 14 163 |
| Gross margin | 45.7% | 46.4% | -0.7% | 46.4% | 46.6% | -0.2% | 46.8% | 46.8% |
| EBITA* | 788 | 715 | 10.2% | 1 408 | 1 432 | -1.7% | 4 155 | 4 179 |
| EBITA margin* | 11.4% | 10.0% | 1.4% | 10.6% | 10.3% | 0.3% | 14.0% | 13.8% |
| Operating profit | 473 | 428 | 10.5% | 789 | 762 | 3.5% | 2 756 | 2 729 |
| Profit before tax | 311 | 243 | 28.0% | 468 | 388 | 20.6% | 2 077 | 1 997 |
| Net profit | 227 | 177 | 28.2% | 342 | 283 | 20.8% | 1 516 | 1 457 |
| Earnings per share | 0.93 | 0.71 | 31.0% | 1.39 | 1.09 | 27.5% | 6.13 | 5.83 |
| Cash flow from operations | 463 | 598 | -22.6% | 1 163 | 1 252 | -7.1% | 3 369 | 3 458 |
* before restructuring, acquisition and integration cost
Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. With a genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers – improving the every-day life for people, today and tomorrow.
The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
Tags: